Mental health news

Infographic: Long-term benzodiazepine use widespread, finds study

Infographic: Long-term benzodiazepine use widespread, finds study

Long-term use of benzodiazepines is a significant problem...

Earn 5 CPD credits at free MIMS workshop on mental health and type 2 diabetes

Earn 5 CPD credits at free MIMS workshop on mental health and type 2 diabetes

Healthcare professionals are invited to attend a complimentary...

Citalopram: suspected interaction with cocaine

Citalopram: suspected interaction with cocaine

Healthcare professionals should be aware of the potential...

Varenicline does not increase risk of psychiatric events, study confirms

Varenicline does not increase risk of psychiatric events, study confirms

Additional side-effect monitoring is no longer required...

Infographic: Inappropriate prescribing of antidepressants in children and adolescents

Infographic: Inappropriate prescribing of antidepressants in children and adolescents

Prescribing of antidepressants in children and adolescents...

GPs asked to use new valproate pregnancy risk communication materials

GPs asked to use new valproate pregnancy risk communication materials

Healthcare professionals are being sent printed communication...

MIMS guidance on switching and withdrawing antidepressants updated

MIMS guidance on switching and withdrawing antidepressants updated

Advice on switching and withdrawing antidepressants...

NICE recommends multimodal antidepressant for depressive episodes

NICE recommends multimodal antidepressant for depressive episodes

Vortioxetine (Brintellix) has been approved by NICE...

Vortioxetine: New for depressive episodes

Vortioxetine: New for depressive episodes

Brintellix (vortioxetine) is indicated for the treatment...

Study highlights inappropriate prescribing in patients with learning disabilities

Study highlights inappropriate prescribing in patients with learning disabilities

One in six adults with learning disabilities is being...

New treatment option for adolescents with schizophrenia

New treatment option for adolescents with schizophrenia

The licensing of Invega (paliperidone) has been extended...

Hydroxyzine: risk of QT prolongation and torsade de pointes

Hydroxyzine: risk of QT prolongation and torsade de pointes

Prescribing recommendations for the use of hydroxyzine...

Prescribe pregabalin by brand for pain, GPs told

Prescribe pregabalin by brand for pain, GPs told

Pregabalin should only be prescribed for the treatment...

Anafranil SR discontinued

Anafranil SR discontinued

Valproate use in women restricted

Valproate use in women restricted

Valproate should not be prescribed to female patients...

News in brief - January 2015 (updated)

News in brief - January 2015 (updated)

Other new launches, licence changes and updates relevant...

News in brief - CNS disorders

Latuda: new atypical antipsychotic

Latuda: new atypical antipsychotic

Latuda (lurasidone) is a new atypical antipsychotic...

Blood drug levels to be set in new driving offence

Blood drug levels to be set in new driving offence

A new offence of driving with certain controlled drugs...

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.